The radscore distribution between negative and positive ALK mutation patients in the training group and test group respectively were shown in Figure 3C, Supplementary Figures S1C and S2C, we found that all 3 radiomic models can predict the ALK mutation status in lung adenocarcinoma patients (Table 2). This evidence concerns the gene ALK and lung adenocarcinoma.